317 related articles for article (PubMed ID: 27668856)
1. Tumor microenvironment-mediated chemoresistance in breast cancer.
Velaei K; Samadi N; Barazvan B; Soleimani Rad J
Breast; 2016 Dec; 30():92-100. PubMed ID: 27668856
[TBL] [Abstract][Full Text] [Related]
2. Breast tumor stroma: A driving force in the development of resistance to therapies.
Majidinia M; Yousefi B
Chem Biol Drug Des; 2017 Mar; 89(3):309-318. PubMed ID: 28042683
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment promotes breast cancer chemoresistance.
Mehraj U; Dar AH; Wani NA; Mir MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):147-158. PubMed ID: 33420940
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells.
Skolekova S; Matuskova M; Bohac M; Toro L; Durinikova E; Tyciakova S; Demkova L; Gursky J; Kucerova L
Cell Commun Signal; 2016 Jan; 14():4. PubMed ID: 26759169
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mediated therapeutic resistance in breast cancer.
Tan C; Hu W; He Y; Zhang Y; Zhang G; Xu Y; Tang J
Cytokine; 2018 Aug; 108():151-159. PubMed ID: 29609137
[TBL] [Abstract][Full Text] [Related]
7. The Role of Stroma in Tumor Development.
Werb Z; Lu P
Cancer J; 2015; 21(4):250-3. PubMed ID: 26222075
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
Plava J; Cihova M; Burikova M; Matuskova M; Kucerova L; Miklikova S
Mol Cancer; 2019 Mar; 18(1):67. PubMed ID: 30927930
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.
Dauer P; Nomura A; Saluja A; Banerjee S
Pancreatology; 2017; 17(1):7-12. PubMed ID: 28034553
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
Thibault B; Castells M; Delord JP; Couderc B
Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
13. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
[TBL] [Abstract][Full Text] [Related]
14. SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.
Otte A; Yang Y; von der Ohe J; Melzer C; Hillemanns P; Feuerhake F; Hass R
Int J Oncol; 2016 Dec; 49(6):2453-2463. PubMed ID: 27748897
[TBL] [Abstract][Full Text] [Related]
15. Tumor-stroma crosstalk: targeting stroma in breast cancer.
Criscitiello C; Esposito A; Curigliano G
Curr Opin Oncol; 2014 Nov; 26(6):551-5. PubMed ID: 25279962
[TBL] [Abstract][Full Text] [Related]
16. [Advances in study of macrophages in chemotherapy resistance of cancer].
Chen HH; Liang GK; Yao ZT; Zhang JQ; Chen X; Ding L
Yao Xue Xue Bao; 2016 Oct; 51(10):1513-9. PubMed ID: 29924574
[TBL] [Abstract][Full Text] [Related]
17. Microenvironment in breast tumorigenesis: Friend or foe?
Martins D; Schmitt F
Histol Histopathol; 2019 Jan; 34(1):13-24. PubMed ID: 29978449
[TBL] [Abstract][Full Text] [Related]
18. Platelets surrounding primary tumor cells are related to chemoresistance.
Ishikawa S; Miyashita T; Inokuchi M; Hayashi H; Oyama K; Tajima H; Takamura H; Ninomiya I; Ahmed AK; Harman JW; Fushida S; Ohta T
Oncol Rep; 2016 Aug; 36(2):787-94. PubMed ID: 27349611
[TBL] [Abstract][Full Text] [Related]
19. The biology and function of fibroblasts in cancer.
Kalluri R
Nat Rev Cancer; 2016 Aug; 16(9):582-98. PubMed ID: 27550820
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications.
Cives M; Pelle' E; Quaresmini D; Rizzo FM; Tucci M; Silvestris F
Neuroendocrinology; 2019; 109(2):83-99. PubMed ID: 30699437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
